Table 3.
Adverse Effect | Grade 1–2 | Grade 3–4 |
---|---|---|
Fatigue | 15 (65%) | 1 (4%) |
Hypotension | 16 (70%) | 0 |
Nausea/vomiting | 17 (74%) | 0 |
Hypocalcemia | 7 (30%) | 1 (4%) |
Hyponatremia | 0 | 3 (13%) |
Pericarditis | 0 | 1 (4%) |
Anaphylaxis | 0 | 1(1%) |
Adverse Effect | Grade 1–2 | Grade 3–4 |
---|---|---|
Fatigue | 15 (65%) | 1 (4%) |
Hypotension | 16 (70%) | 0 |
Nausea/vomiting | 17 (74%) | 0 |
Hypocalcemia | 7 (30%) | 1 (4%) |
Hyponatremia | 0 | 3 (13%) |
Pericarditis | 0 | 1 (4%) |
Anaphylaxis | 0 | 1(1%) |